Shing-Hu Cheung is a seasoned professional in oncology research with extensive experience at Bayer since September 2013, where roles have included Scientific Program Leader, Director of Oncology Precision Medicine, and Associate Director of Senior Biomarker Strategist in Translational Medicine Oncology. Key responsibilities included leading biomarker strategies, developing companion diagnostics for specific cancer treatments, and managing external collaborations to enhance drug discovery efforts. Prior experience at BeiGene involved leading preclinical discovery projects, including a novel RAF inhibitor, while earlier positions included research investigator roles at Centaurus BioPharma and various academic research positions. Shing-Hu Cheung holds a PhD in Cell Biology and Biochemistry from the University of Nottingham and has undergraduate degrees in Biochemistry and Molecular Biology, and Microbiology, Immunology and Molecular Genetics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices